The Interplay Between CA19‐9 and the Lewis Blood Group System: Implications for the Diagnosis of Gallbladder Cancer
Canadian Journal of Gastroenterology and Hepatology · 2025-01 · 2025 (1)
DOI: 10.1155/cjgh/8465615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, online erschienen am 14.11.2025. Verfasst von Yuhan Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China, jxndefy.cn. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, CA-19-9 Antigen, Biomarkers, Tumor, Lewis Blood Group Antigens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
CA19‐9 is one of the most widely applied tumor markers in clinical oncology, particularly in the diagnosis and prognostic evaluation of biliary tract and pancreatic cancers. However, its clinical utility is limited by biological variability, most notably the influence of the Lewis blood group system, which may result in false‐negative findings. The Lewis system is composed of three major phenotypes, Le(a+b−), Le(a−b+), and Le(a−b−), with the less frequent Le(a+b+) also reported in certain populations. Current evidence indicates that CA19‐9 expression occurs predominantly in Le(a+b−) or Le(a−b+) individuals, whereas it is largely absent in Le(a−b−) individuals. Insufficient consideration of this factor in clinical settings reduces diagnostic accuracy and complicates interpretation of CA19‐9 results. This review summarizes the current understanding of the relationship between CA19‐9 and the Lewis system, critically evaluates recent clinical studies, highlights existing limitations, and discusses the potential role of combined CA19‐9 and Lewis typing in improving the diagnostic value of gallbladder cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China, jxndefy.cn.
- Queen Mary School, Nanchang University, Nanchang, Jiangxi, 330006, China, ncu.edu.cn.
- The Second Clinical Medical School, Nanchang University, Nanchang, Jiangxi, 330006, China, ncu.edu.cn.
- Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, 330006, China, ncu.edu.cn.
ORCID-Profile: Yuhan Liu, Jiamao Zhang, Zitong Zheng, Wenjuan Zheng, Fan Zhou, Bo Liang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Liu, Y., Zhang, J., Zheng, Z., Zheng, W., Fang, L., Zhou, F., & Liang, B. (2025). The Interplay Between CA19‐9 and the Lewis Blood Group System: Implications for the Diagnosis of Gallbladder Cancer. Canadian Journal of Gastroenterology and Hepatology, 2025(1). https://doi.org/10.1155/cjgh/8465615
Vancouver
Liu Y, Zhang J, Zheng Z, Zheng W, Fang L, Zhou F, et al. The Interplay Between CA19‐9 and the Lewis Blood Group System: Implications for the Diagnosis of Gallbladder Cancer. Canadian Journal of Gastroenterology and Hepatology. 2025;2025(1). doi:10.1155/cjgh/8465615
BibTeX
@article{Liu2025,
author = {Liu, Yuhan and Zhang, Jiamao and Zheng, Zitong and Zheng, Wenjuan and Fang, Lu and Zhou, Fan and Liang, Bo},
title = {The Interplay Between CA19‐9 and the Lewis Blood Group System: Implications for the Diagnosis of Gallbladder Cancer},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/cjgh/8465615}
}
EUVIMED